| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CARDIORES.2007.03.021 |
| P698 | PubMed publication ID | 17466958 |
| P2093 | author name string | Y Blaauw | |
| M A Allessie | |||
| H R Neuberger | |||
| U Schotten | |||
| A van Hunnik | |||
| P433 | issue | 1 | |
| P921 | main subject | atrial fibrillation | Q815819 |
| cardioversion | Q1729126 | ||
| P304 | page(s) | 89-98 | |
| P577 | publication date | 2007-03-30 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat | |
| P478 | volume | 75 |
| Q42777572 | Advances in the Pharmacologic Management of Atrial Fibrillation |
| Q49183821 | Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses. |
| Q36013079 | Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity |
| Q37584282 | Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation |
| Q37494653 | Atrial-selective sodium channel block for the treatment of atrial fibrillation. |
| Q36646001 | Cell-specific nanoplatform-enabled photodynamic therapy for cardiac cells. |
| Q64924634 | Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs. |
| Q37359211 | Information learned from animal models of atrial fibrillation |
| Q42459986 | Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation |
| Q37406359 | K+ current changes account for the rate dependence of the action potential in the human atrial myocyte |
| Q39568164 | Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium. |
| Q37844891 | Mechanisms of termination and prevention of atrial fibrillation by drug therapy |
| Q37106294 | New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation |
| Q37697498 | New developments in atrial antiarrhythmic drug therapy |
| Q37184197 | New drugs for atrial fibrillation |
| Q35489060 | Novel pharmacological targets for the rhythm control management of atrial fibrillation. |
| Q36842497 | Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation |
| Q38085529 | Rotors and the dynamics of cardiac fibrillation |
| Q33943789 | Selective molecular potassium channel blockade prevents atrial fibrillation |
| Q33911538 | The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models. |
Search more.